Lamotrigine Tablet
Product Images NDC 82009-131

11 FDA label images from Quallent Pharmaceuticals Health Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 82009-131). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Lamotrigine (E52b9712 Bb48 4172 B25c 2a9ba75a41ec 01)

Structured Formula For Lamotrigine (E52b9712 Bb48 4172 B25c 2a9ba75a41ec 01)
Chemical structure of lamotrigine showing the molecular arrangement including chlorine atoms and an aminotriazine ring.*
FDA Label Image

Lamotrigine Tablet (E52b9712 Bb48 4172 B25c 2a9ba75a41ec 02)

Lamotrigine Tablet (E52b9712 Bb48 4172 B25c 2a9ba75a41ec 02)
A Kaplan-Meier curve showing failure probability (%) over time in weeks for Lamotrigine and Placebo groups. The graph plots failure probability on the vertical axis and weeks on the horizontal axis. The Lamotrigine group has a lower failure probability across most weeks compared to the Placebo group. Censored data points are marked on both curves.*
FDA Label Image

Lamotrigine Tablets (E52b9712 Bb48 4172 B25c 2a9ba75a41ec 03)

Lamotrigine Tablets (E52b9712 Bb48 4172 B25c 2a9ba75a41ec 03)
A Kaplan-Meier failure probability curve comparing Lamotrigine and placebo over approximately 80 weeks. The vertical axis represents Failure Probability (%) and the horizontal axis shows Weeks. The plot includes censored data points marked on both the Lamotrigine and placebo lines, with Lamotrigine showing a lower failure probability compared to placebo throughout most of the study period.*
FDA Label Image

Image (8e46ac1d 4e2d 4769 B4fd Dc72db327524 388 2)

Image (8e46ac1d 4e2d 4769 B4fd Dc72db327524 388 2)
Image of a round oral tablet imprinted with "ZC" above the score line and "79" below it. This tablet corresponds to Lamotrigine, available in various strengths including 100 mg, 150 mg, 200 mg, and 25 mg, manufactured by Quallent Pharmaceuticals Health LLC.*
FDA Label Image

Image (8e46ac1d 4e2d 4769 B4fd Dc72db327524 388 3)

Image (8e46ac1d 4e2d 4769 B4fd Dc72db327524 388 3)
Tablet marked with "ZC" above a score line and "80" below. The image shows the imprint identifying the Lamotrigine 100 mg oral tablet by Quallent Pharmaceuticals Health LLC.*
FDA Label Image

Image (8e46ac1d 4e2d 4769 B4fd Dc72db327524 388 4)

Image (8e46ac1d 4e2d 4769 B4fd Dc72db327524 388 4)
Lamotrigine 25 mg oral tablet imprinted with 'ZC' on the top half and '81' on the bottom half. The tablet is round and white, associated with Quallent Pharmaceuticals Health LLC.*
FDA Label Image

Image (8e46ac1d 4e2d 4769 B4fd Dc72db327524 388 5)

Image (8e46ac1d 4e2d 4769 B4fd Dc72db327524 388 5)
Lamotrigine 25 mg oral tablet imprint showing a round white tablet divided by a score line, with the letters 'ZC' above the line and the number '82' below. This imprint identifies the tablet supplied by Quallent Pharmaceuticals Health LLC.*
FDA Label Image

Lamotrigine Tablets Usp, 25 mg (E52b9712 Bb48 4172 B25c 2a9ba75a41ec 04)

Lamotrigine Tablets Usp, 25 mg (E52b9712 Bb48 4172 B25c 2a9ba75a41ec 04)
Label for Lamotrigine Tablets USP 25 mg by Quallent Pharmaceuticals Health LLC. The label indicates 1,000 tablets in the package with NDC 82009-131-10. It includes storage instructions, a caution to verify product dispensed, and a pharmacist note to dispense the Medication Guide separately. The label also notes the manufacturer is Zydus Lifesciences Ltd., India.*
FDA Label Image

Lamotrigine Tablets Usp, 100 mg (E52b9712 Bb48 4172 B25c 2a9ba75a41ec 05)

Lamotrigine Tablets Usp, 100 mg (E52b9712 Bb48 4172 B25c 2a9ba75a41ec 05)
Lamotrigine 100 mg tablets, USP label for oral administration. The label shows a package containing 1,000 tablets. It is manufactured by Zydus Lifesciences Ltd., India, and labeled for Quallent Pharmaceuticals Health LLC. The label includes dosage strength, storage conditions, barcode, and cautionary information about dispensing the medication guide.*
FDA Label Image

Lamotrigine Tablets Usp, 150 mg (E52b9712 Bb48 4172 B25c 2a9ba75a41ec 06)

Lamotrigine Tablets Usp, 150 mg (E52b9712 Bb48 4172 B25c 2a9ba75a41ec 06)
Lamotrigine Tablets USP 150 mg oral tablets label from Quallent Pharmaceuticals Health LLC. The label shows a package size of 500 tablets, with the NDC 82009-133-05. It includes dosage strength, storage instructions, cautions, and manufacturer information. The label mentions the need to dispense the Medication Guide separately and keep the product out of children's reach.*
FDA Label Image

Lamotrigine Tablets Usp, 200 mg (E52b9712 Bb48 4172 B25c 2a9ba75a41ec 07)

Lamotrigine Tablets Usp, 200 mg (E52b9712 Bb48 4172 B25c 2a9ba75a41ec 07)
Lamotrigine Tablets, USP 200 mg oral tablets, packaged in a 500-count container. The label includes dosage strength, storage instructions at 20°C to 25°C, caution notes about the printed seal, and pharmacist dispensing guidelines. Manufactured by Zydus Lifesciences Ltd., India, for Quallent Pharmaceuticals Health LLC, Grand Cayman, Cayman Islands.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.